VTRS News and Press, Viatris Inc. From 02/17/26

2026-02-17 17:27:10 ET More on PayPal, Pinterest, etc. PayPal: Despite Uncertainty, Stock Remains A Buy Pinterest: The Market Has Lost Its Mind, 25% Net Cash, Big Buybacks PayPal Vs. Fiserv: Which Is The Better Comeback Bet? SA Asks: Which financial stocks ar...

2026-02-17 06:23:00 ET This is what dividend investing is all about! Investing in dividend stocks allows you to earn dividend income, the best passive income stream! Bias, you better believe it.... Read the full article on Seeking Alpha For further details see: Divid...

2026-02-15 09:05:11 ET More on State Street Health Care Select Sector SPDR ETF Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More CMS Rates Proposal Shatters Health Insurance Stocks: What Investors Must Know (& Do) Insurers Brac...

2026-02-09 13:44:53 ET More on Viatris 44th Annual J.P. Morgan Healthcare Conference Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Viatris: Looks Cheap, But Faces Continued Contraction Large-cap stocks with lowest di...

2026-02-09 05:15:06 ET UBS analyst issues BUY recommendation for VTRS on February 9, 2026 10:05AM ET. The previous analyst recommendation was Sell. VTRS was trading at $14.58 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analys...

2026-02-06 07:55:57 ET More on large cap stocks Crown Castle Inc. (CCI) Q4 2025 Earnings Call Transcript Crown Castle Inc. 2025 Q4 - Results - Earnings Call Presentation Pfizer Inc. 2025 Q4 - Results - Earnings Call Presentation President Trump unveils TrumpR...

2026-02-04 11:47:46 ET More on Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript Seeking Alpha’s Quant Rating on Hikma Pharmaceuticals PLC Historical earnings data for Hikma Pharmaceuticals PLC Dividend sco...

NESS ZIONA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, will present new safety and efficacy data from the GA Depot Phase II stu...

Viatris Appoints Matthew J. Maletta as Chief Legal Officer PR Newswire Brian Roman to Leave the Company After More Than 20 Years of Exemplary Service; Will Remain Advisor Through Transition Period  PITTSBURGH , Feb. 3, 2026 /PRNewswire/ --  Viatris Inc. (Nasd...

2026-02-02 20:49:20 ET This article is part of a series that provides an ongoing analysis of the changes made to Davis Selected Advisers’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/02/2026. Please visit our Tracking Christopher ...